← Back to Search

Cognitive Remediation Therapy for Depression (CogRemVet Trial)

N/A
Recruiting
Led By Erin A Hazlett-Oakes, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in pre-treatment score minus post-treatment score (week 10)
Awards & highlights

CogRemVet Trial Summary

This trial is testing a new cognitive remediation therapy that includes "Bridging" sessions to help Veterans with major depressive disorder and a history of suicide attempt(s).

Who is the study for?
This trial is for U.S. Veterans aged 18-60 with major depressive disorder and a history of suicide attempts within the past year. They must have current suicidal thoughts without immediate plans to act on them, be in ongoing psychotherapy, and score high on rumination measures. Women are encouraged to participate, aiming for at least 30% female participants.Check my eligibility
What is being tested?
The study tests a new cognitive therapy called NEAR (Cognitive Remediation plus Bridging) delivered via telehealth over 10 weeks with 20 sessions. It's designed to help veterans improve decision-making and manage stressors that could lead to suicidal thoughts by practicing problem-solving strategies.See study design
What are the potential side effects?
Since this intervention involves educational and therapeutic activities rather than medication, typical medical side effects are not expected. However, participants may experience emotional discomfort or fatigue during mental exercises.

CogRemVet Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in pre-treatment score minus post-treatment score (week 10)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in pre-treatment score minus post-treatment score (week 10) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mental Depression

CogRemVet Trial Design

1Treatment groups
Experimental Treatment
Group I: Cognitive Remediation+Bridging InterventionExperimental Treatment1 Intervention
This is a pilot study to collect feasibility data on this novel cognitive remediation intervention for Veterans at high risk for suicide. All patients will receive the active intervention.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,610 Previous Clinical Trials
3,305,148 Total Patients Enrolled
77 Trials studying Depression
20,689 Patients Enrolled for Depression
Erin A Hazlett-Oakes, PhDPrincipal InvestigatorJames J. Peters Veterans Affairs Medical Center

Media Library

Neuropsychological Educational Approach to Cognitive Remediation (NEAR, termed Cognitive Remediation plus Bridging) Clinical Trial Eligibility Overview. Trial Name: NCT04952532 — N/A
Depression Research Study Groups: Cognitive Remediation+Bridging Intervention
Depression Clinical Trial 2023: Neuropsychological Educational Approach to Cognitive Remediation (NEAR, termed Cognitive Remediation plus Bridging) Highlights & Side Effects. Trial Name: NCT04952532 — N/A
Neuropsychological Educational Approach to Cognitive Remediation (NEAR, termed Cognitive Remediation plus Bridging) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04952532 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial open to participants of twenty-one or older?

"This research is looking for eligible participants aged 18 to 60 years old."

Answered by AI

Are there any open vacancies for participants in this medical trial?

"Affirmative. Per clinicaltrials.gov, this medical research is presently searching for participants. This trial was first made available on January 1st 2022 and has been updated as recently as the 20th of January 20202. 36 subjects must be enrolled to fulfill the study's requirements across one site."

Answered by AI

What are the eligibility criteria for participating in this trial?

"This clinical trial seeks 36 participants aged between 18 and 60 who have involutional psychosis. In addition to the age requirement, potential volunteers need to be US veterans with a primary diagnosis of major depressive disorder (MDD) as well as an elevated score on the rumination measure (Ruminative Response Scale). Additionally, they must exhibit either passive suicidal ideation or active ideation without intent nor plan based on their C-SSRS rating. Furthermore, these subjects should already be in psychotherapy at James J. Peters VA Medical Center and 30% of them should be female."

Answered by AI

How many individuals have become involved in this trial thus far?

"That is accurate. The trial, which was initially uploaded to clinicaltrials.gov on January 1st 2022, remains open for recruitment and seeks 36 individuals from a single location."

Answered by AI

Who else is applying?

What site did they apply to?
James J. Peters VA Medical Center, Bronx, NY
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
A Novel Cognitive Remediation Intervention Targeting Poor Decision-making and Depression in Veterans at High Risk for Suicide: A Safe, Telehealth Approach During the COVID-19 Pandemic
2022. "A Novel Cognitive Remediation Intervention Targeting Poor Decision-making and Depression in Veterans at High Risk for Suicide: A Safe, Telehealth Approach During the COVID-19 Pandemic". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04952532.
All > Depression New York
~8 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top